Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
December 4, 2011
Heparinex Receives $1.6-Million Award to Enable CMC for Proprietary Delivery Technology December 4, 2011
Heparinex, LLC recently announced the company has received a $1.6-million fund endowment from the Economic Development Generating Excellence program (EDGE)....
November 20, 2011
Bend Research Signs Technology Licensing Agreement With Merck November 20, 2011
Bend Research Inc., a leading independent drug formulation development and manufacturing company, recently announced it has entered into a licensing...
August 25, 2011
Tekmira Acquires Worldwide Exclusive License to Novel RNAi Platform August 25, 2011
Tekmira Pharmaceuticals Corporation recently announced it has obtained an exclusive, worldwide license to a novel and proprietary RNAi technology called...
July 17, 2011
Life Technologies Develops Potent Drug Delivery Technology for Therapeutics Market July 17, 2011
Life Technologies corporation recently announced it has developed new drug delivery technology specially designed for therapeutic applications that is 100-fold...
June 20, 2011
Pulmatrix Shows iSPERSE Effectively Delivers Doses of Multi-Drug Formulations June 20, 2011
Pulmatrix recently announced that data relating to the preclinical efficacy and multi-drug formulation and delivery capabilities of the company's novel...
June 6, 2011
3M Signs Development Agreement; Updates Phosphagenics Collaboration June 6, 2011
3M Drug Delivery Systems and Radius Health, Inc. recently announced an agreement to collaborate on the development of a transdermal...
May 23, 2011
Critical Outcome Technologies Initiates Development of Optimal Oral Oncology Formulation May 23, 2011
Critical Outcome Technologies Inc. recently announced it has initiated a project to develop an optimal oral formulation of COTI-2. This...
February 14, 2011
Capsugel Acquires Novel FlexTab Delivery Technology February 14, 2011
Capsugel, the world's leading hard capsule manufacturer and an innovator in drug delivery systems, recently announced its acquisition of the FlexTabTM...
June 17, 2025
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Custome June 17, 2025
CHASKA, Minn., Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed...
June 13, 2025
BioNTech Announces Strategic Transaction to Acquire CureVac June 13, 2025
BioNTech SE and CureVac N.V. recently announced they have entered into a definitive Purchase Agreement pursuant to which BioNTech intends to...
June 4, 2025
Elicio Therapeutics Secures $10 Million in Financing June 4, 2025
Elicio Therapeutics, Inc. recently announced it has entered a $10-million senior secured promissory note with existing investor, GKCC, LLC. The...
June 3, 2025
EXECUTIVE INTERVIEW - Adare Pharma Solutions: Fast, Flexible, and Focused: The Secrets of a Successful CDMO Partnership June 3, 2025
Steven Facer, Senior Vice President of Sales and Marketing at Adare Pharma Solutions, shares practical insights on what makes CDMO partnerships work and what can cause them to fall short.
May 14, 2025
Hovione & Firstgene Announce Strategic Collaboration to Advance Virus-Like Particle Platform for Liver Cancer May 14, 2025
Hovione and Firstgene Life Sciences recently announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for...
May 13, 2025
Alzamend Neuro Initiates First Phase 2 Trial of AL001 “Lithium in Brain” Study May 13, 2025
Alzamend Neuro, Inc. recently today announced the initiation of the first of five Phase 2 clinical studies of AL001, with...
May 7, 2025
SPECIAL FEATURE - PFS & Parenteral Delivery: Innovation Is Focused on Patient-Centric, Smart & Sustainable Solutions May 7, 2025
Contributor Cindy H. Dubin speaks with several innovating companies to discuss trends in PFS as well as advancements in autoinjectors and innovations in parenteral delivery.
May 6, 2025
EXECUTIVE INTERVIEW - MediWound Ltd.: Developing a New Class of Biologic Enzymatic Therapeutic Products to Debride Wounds May 6, 2025
Ofer Gonen, Chief Executive Officer of MediWound, discusses the company’s innovative approach to debridement.
April 24, 2025
Inmagene Reports Topline Results From Phase 2a Study of a Nondepleting Anti-OX40 Monoclonal Antibody With an Extended Half-Life in Patients With Alopecia Areata April 24, 2025
Inmagene Biopharmaceuticals recently reports topline results from the Phase 2a trial of IMG-007 in patients with severe alopecia areata (AA)....
April 17, 2025
Ligand Subsidiary Pelthos Therapeutics to Combine With Channel Therapeutics April 17, 2025
Ligand Pharmaceuticals Incorporated and Channel Therapeutics Corporation recently announced the signing of a definitive merger agreement to combine Ligand’s wholly...
March 18, 2025
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine March 18, 2025
Curevo Vaccine recently announced the closing of a $110-million Series B round to advance development of amezosvatein, its vaccine for...
March 14, 2025
Polyrizon Signs Non–Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments March 14, 2025
Polyrizon Ltd. recently announced it has signed a non-binding Letter of Intent (LOI) with a biotech company focused on psychedelic-derived...Company Profiles
December 1, 2024
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...
October 31, 2024
DRUG-DEVICE DEVELOPMENT - Exploring the Complexities of Drug-Device Combination Products
Jeremy Guo, Senior Vice President at WuXi Biologics, and colleagues explain that many factors need to be taken into account when producing a Drug-Device Combination Product from development testing to fill/finish and assembly.
